Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
HRMY Harmony Biosciences
- 29.440
- 0.0000.00%
Close Apr 29 16:00 ET
- 29.190
- -0.250-0.85%
Pre 08:41 ET
1.69BMarket Cap11.73P/E (TTM)
0.000High0.000Low101Volume0.000Open29.440Pre Close0.00Turnover0.00%Turnover Ratio11.73P/E (Static)57.39MShares41.61052wk High2.56P/B1.31BFloat Cap26.47052wk Low--Dividend TTM44.43MShs Float62.085Historical High--Div YieldTTM0.00%Amplitude18.611Historical Low0.000Avg Price1Lot Size
About Harmony Biosciences Company
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Company Profile
SymbolHRMY
Company NameHarmony Biosciences
Listing DateAug 19, 2020
Issue Price24.00
Founded2017
CEODr. Jeffrey M. Dayno, M.D.
MarketNASDAQ
Employees268
Fiscal Year Ends12-31
Address630 West Germantown Pike,Suite 215
CityPlymouth Meeting
ProvincePennsylvania
CountryUnited States of America
Zip Code19462
Phone1-484-539-9800
Company Executives
- Name
- Position
- Salary
- Dr. Jeffrey M. Dayno, M.D.
- Chief Executive Officer, President and Director
- 7.15M
- Sandip S. Kapadia, C.P.A.,M.B.A.
- Chief Financial Officer, Principal Accounting Officer and Chief Administrative Officer
- 3.07M
- Kumar Budur
- Chief Medical Officer
- 5.73M
- Andrew Serafin
- Chief Strategy Officer
- 2.09M
- Jeffrey S. Aronin
- Chairman of the Board
- 40.00K
- Ron Philip
- Independent Director
- --
- Linda M. Szyper
- Independent Director
- 175.01K
- R. Mark Graf
- Independent Director
- 180.01K
- Peter Anastasiou
- Independent Director
- 178.01K
- Juan A. Sabater
- Independent Director
- 180.01K
- Gary L. Sender
- Independent Director
- 302.99K
- Antonio J. Gracias
- Independent Director
- 235.01K
- Dr. Andreas Wicki, PhD
- Independent Director
- --
- Adam Zaeske
- Executive Vice President and Chief Commercial Officer
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now